BRCA1 and breast cancer: Our study is an advancement over previous ones due to the incorporation of variables from up-to-date peer-reviewed studies considering the type of pathogenic variant (BRCA1 or BRCA2), age at primary breast cancer diagnosis, breast cancer subtype and stage, status of systemic treatment received.